Try our beta test site
38 studies found for:    Open Studies | "Chorea"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Open Label Extension Study To Investigate Long Term Safety, Tolerability And Efficacy Of Pf-02545920 In Subjects With Huntington's Disease Who Completed Study A8241021
Condition: Huntington's Disease
Intervention: Drug: 20 mg BID of PF-02545920
2 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention: Other: Botulinum Toxin
3 Recruiting Deep Brain Stimulation (DBS) of the Globus Pallidus (GP) in Huntington's Disease (HD)
Condition: Huntington Disease
Intervention: Device: ACTIVA® PC neurostimulator (Model 37601)
4 Available Compassionate Use of Tetrabenazine in the Treatment of Abnormal Movements
Condition: Hyperkinetic Movement Disorders
Intervention: Drug: tetrabenazine
5 Not yet recruiting Is Caffeine an Environmental Modifier in Huntington's Disease?
Condition: Huntington Disease
Intervention:
6 Not yet recruiting A Study to Evaluate Sigma-1 and Dopamine-2 Receptor Occupancy by Pridopidine in the Human Brain of Healthy Volunteers and in Patients With Huntington's Disease
Condition: Health Volunteers, Huntington Disease
Intervention: Drug: pridopidine (90 mg)
7 Recruiting Exploring Computerised Cognitive Training for People With Huntington's Disease
Condition: Huntington's Disease
Intervention: Behavioral: Computerised cognitive training
8 Recruiting Follow-up Measurement of Brain PDE10A Enzyme Levels in Huntington´s Disease Gene Expansion Carriers
Condition: Huntington's Disease
Intervention: Radiation: Radioligand [18F]MNI-659
9 Not yet recruiting FuRST 2.0 Cognitive Pre-Testing
Condition: Huntington's Disease
Intervention: Behavioral: FuRST 2.0
10 Recruiting HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Development for Huntington's Disease
Condition: Huntington's Disease
Intervention:
11 Not yet recruiting Safety Evaluation of Cellavita HD Administered Intravenously in Participants With Huntington's Disease
Condition: Huntington Disease
Interventions: Other: Cellavita HD lower dose;   Other: Cellavita HD intermediate dose;   Other: Cellavita HD Higher dose
12 Recruiting Dynamic Neuroimaging Biomarkers in Huntington's Disease
Condition: Brain Neuroimaging Biomarkers in Huntington Disease
Intervention:
13 Recruiting Feasibility of a Video-oculography in Patients With Huntington's Disease VOG-HD Study
Condition: Huntington Disease
Intervention: Device: Eye-tracking
14 Not yet recruiting Functional Imaging of Social Cognition in Premanifest Huntington's Disease
Condition: Huntington's Disease
Intervention: Other: functional Imaging
15 Recruiting Social Cognition in Huntington's Disease: Cognitive Study and Functional and Morphological Imaging
Condition: Huntington's Disease
Interventions: Behavioral: neuropsychological test;   Radiation: MRI
16 Recruiting Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IONIS-HTTRx in Patients With Early Manifest Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: IONIS HTTRx;   Drug: Placebo
17 Recruiting A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine)
Condition: Huntington's Disease
Intervention: Drug: Tetrabenazine
18 Recruiting Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease
Conditions: Irritable Mood;   Huntington's Disease
Interventions: Drug: SRX246;   Drug: Placebo
19 Recruiting A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease
Condition: Huntington Disease
Interventions: Drug: Triheptanoin oil;   Drug: Placebo
20 Recruiting Resveratrol and Huntington Disease
Condition: Huntington Disease
Interventions: Dietary Supplement: Resveratrol;   Other: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-38) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.